SNAI1 is a zinc-finger transcriptional repressor that functions as a master regulator of epithelial-mesenchymal transition (EMT) and cellular plasticity across multiple biological contexts. Mechanistically, SNAI1 binds E-box elements in the E-cadherin promoter and recruits histone demethylase KDM1A to suppress epithelial gene expression 12. During EMT, SNAI1 cooperates with LOXL2 to repress pericentromeric heterochromatin transcription, facilitating chr20 reorganization required for mesenchymal transition 3. SNAI1 expression is dynamically regulated: a SNAI1 enhancer RNA (SNAI1e) drives SNAI1 expression through BRD4 recruitment and strengthens TGF-β/SMAD signaling 4, while UDP-glucose promotes SNAI1 mRNA degradation through HuR modulation, suppressing metastatic capacity 5. In cancer biology, SNAI1 promotes aggressive phenotypes across multiple malignancies. In thymic epithelial tumors, SNAI1 maintains cancer stem cell properties via the PIK3R2/p-EphA2 axis 6. SNAI1 expression is sustained in mesenchymal pancreatic cancer cells, where BMP inhibition by GREM1 restricts its expression to maintain epithelial populations 7. In renal fibrosis, WNT5A/CD146/JNK signaling promotes SNAI1 expression through c-JUN/KLF5 interaction at the SNAI1 promoter 8. Beyond cancer, SNAI1 regulates arginase-1 transcription in ovarian cancer-associated fibroblasts 9 and participates in extravillous trophoblast differentiation during placentation 10. These diverse roles establish SNAI1 as a central node in EMT-driven pathological and developmental processes.